Aristada once-monthly (aripiprazole lauroxil once-monthly formulation) / Alkermes  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Aristada once-monthly (aripiprazole lauroxil once-monthly formulation) / Alkermes
NCT01469039 / 2012-003445-15: A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia

Completed
3
623
US, Europe, RoW
ALKS 9072, Placebo
Alkermes, Inc.
Schizophrenia
01/14
03/14
OLE, NCT01626456 / 2012-003996-20: A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)

Completed
3
478
US, Europe, RoW
ALKS 9072, Low, ALKS 9072, High
Alkermes, Inc.
Schizophrenia
04/15
04/15
NCT01895452: An Extension of a Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)

Completed
3
291
US, Europe, RoW
ALKS 9072, Low Dose, ALKS 9072, High Dose
Alkermes, Inc.
Schizophrenia
06/16
06/16

Download Options